Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 184 (abbreviated as RNA5SP184) is classified as a **pseudogene**—a non-coding genomic sequence similar to the gene for 5S ribosomal RNA, but rendered non-functional due to mutations or lack of regulatory elements[2][4][9]. Pseudogenes like RNA5SP184 do **not produce functional 5S ribosomal RNA** and, therefore, **do not participate in ribosome structure or function**. 5S rRNA is an essential RNA component of the large ribosomal subunit critical for protein synthesis in the cell, but pseudogenes in the 5S rRNA family are typically the result of gene duplication or retrotransposition and are **not transcribed or translated into functional molecules**[1][3][8]. While expressed pseudogenes have been associated with regulation or disease in certain contexts, there is **no evidence or characterization of RNA5SP184 as a therapeutic target or as playing a direct functional role in human biology**[2][4][6][7]. It is included in genomic and genetic databases (e.g., HGNC:43084, NCBI Gene:100873446), but these entries confirm its status as a pseudogene[2][4][9].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 184 (RNA5SP184).